Chrystelle Brignone

Polyubiquitination of p53 by a Ubiquitin Ligase Activity of p300

Steven R. Grossman, Maria E. Deato, Chrystelle Brignone et al. · Science · 2003 · 457 citations

MHC Class II Engagement by Its Ligand LAG-3 (CD223) Contributes to Melanoma Resistance to Apoptosis

Patrice Hémon, Francette Jean‐Louis, Kiran Ramgolam et al. · The Journal of Immunology · 2011 · 261 citations · Full text

Ligand Lag-3, Immunology, Immune Regulation +17

First-line chemoimmunotherapy in metastatic breast carcinoma: combination of paclitaxel and IMP321 (LAG-3Ig) enhances immune responses and antitumor activity

Chrystelle Brignone, Maya Gutierrez, F. Mefti et al. · Journal of Translational Medicine · 2010 · 253 citations · Full text

A Phase I Pharmacokinetic and Biological Correlative Study of IMP321, a Novel MHC Class II Agonist, in Patients with Advanced Renal Cell Carcinoma

Chrystelle Brignone, Bernard Escudier, Caroline Grygar et al. · Clinical Cancer Research · 2009 · 234 citations

Eftilagimod alpha, a soluble lymphocyte activation gene-3 (LAG-3) protein plus pembrolizumab in patients with metastatic melanoma

Victoria Atkinson, Adnan Khattak, Andrew Haydon et al. · Journal for ImmunoTherapy of Cancer · 2020 · 106 citations · Full text